|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Gateway 2011: Ropack Inc.
Your online Gateway to Ropack Inc. in 2011
10801 Mirabeau Street,
About Ropack Inc.
Watch our video
Ropack offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages, tablets, powder, and encapsulation into blisters, pouches, bottles, stick packaging and carded blisters. Ropack recently added syringe assembly and vial labeling capabilities. Facilities are cGMP compliant, FDA certified and have 25 Class 100000 production rooms. Ropack is competitive, flexible and agile, supporting clinical trials, short-run start-ups, commercial production for more than 100 U.S., Canadian and European pharmaceutical customers.
Ropack has more than ten years of experience packaging temperature- and humidity-sensitive materials. Our proven record of accomplishment in new product launches will support and accelerate your go-to-market timeline.
See what's new from Ropack's turnkey primary and secondary pharmaceutical and nutraceutical packaging services, including the latest advancements in blisters at Interphex 2011.Now Ropack offers stick packaging – slim, tube-shaped uni-dose packaging of solid oral dosage in a low relative humidity, controlled residual oxygen and temperature-controlled environment. Stick packaging is popular in Japan and Europe for its accuracy and convenience, and now Ropack is advancing stick packaging technology in North America.
Ropack now offers manufacturing and packaging environments to meet even the most exacting specifications. A new 15,000-square-foot dedicated production suite is temperature-controlled with low RH (20%) and controlled residual oxygen (< 2%). Like all Ropack facilities, it is cGMP compliant, FDA certified and Health Canada approved.
For more information:
To schedule a meeting, call or text Paul Dupont, Director of Business Development, at 513 846-0921, or email him: firstname.lastname@example.org.